U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula C14H14N6O2
Molecular Weight 298.3
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 2
Charge 0

SHOW SMILES / InChI
Structure of Resomelagon

SMILES

NC(=N)N\N=C\C=C\C1=CC=CN1C2=CC=CC=C2[N+]([O-])=O

InChI

InChIKey=ZSDGHWLLLGYAJV-AHEHSYJASA-N
InChI=1S/C14H14N6O2/c15-14(16)18-17-9-3-5-11-6-4-10-19(11)12-7-1-2-8-13(12)20(21)22/h1-10H,(H4,15,16,18)/b5-3+,17-9+

HIDE SMILES / InChI

Molecular Formula C14H14N6O2
Molecular Weight 298.3
Charge 0
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 2
Optical Activity NONE

Approval Year

Substance Class Chemical
Created
by admin
on Wed Apr 02 14:27:47 GMT 2025
Edited
by admin
on Wed Apr 02 14:27:47 GMT 2025
Record UNII
NF7M2ZJA9Y
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
Resomelagon
INN  
Official Name English
(2E)-2-{(2E)-3-[1-(2-nitrophenyl)-1H-pyrrol-2-yl]prop-2-en-1-ylidene}hydrazine-1-carboximidamide
Preferred Name English
AP-1189 free base
Code English
Hydrazinecarboximidamide, 2-[(2E)-3-[1-(2-nitrophenyl)-1H-pyrrol-2-yl]-2-propen-1-ylidene]-, (2E)-
Systematic Name English
resomelagon [INN]
Common Name English
AP1189 free base
Code English
Code System Code Type Description
FDA UNII
NF7M2ZJA9Y
Created by admin on Wed Apr 02 14:27:47 GMT 2025 , Edited by admin on Wed Apr 02 14:27:47 GMT 2025
PRIMARY
INN
12136
Created by admin on Wed Apr 02 14:27:47 GMT 2025 , Edited by admin on Wed Apr 02 14:27:47 GMT 2025
PRIMARY
CAS
959850-73-8
Created by admin on Wed Apr 02 14:27:47 GMT 2025 , Edited by admin on Wed Apr 02 14:27:47 GMT 2025
NON-SPECIFIC STEREOCHEMISTRY
CAS
1809420-71-0
Created by admin on Wed Apr 02 14:27:47 GMT 2025 , Edited by admin on Wed Apr 02 14:27:47 GMT 2025
PRIMARY
PUBCHEM
23728926
Created by admin on Wed Apr 02 14:27:47 GMT 2025 , Edited by admin on Wed Apr 02 14:27:47 GMT 2025
PRIMARY
NCI_THESAURUS
C190472
Created by admin on Wed Apr 02 14:27:47 GMT 2025 , Edited by admin on Wed Apr 02 14:27:47 GMT 2025
PRIMARY
Related Record Type Details
TARGET -> AGONIST
Biased agonist: AP1189 reduced cytokine release but no melanogenesis was induced.
SALT/SOLVATE -> PARENT
TARGET -> AGONIST
Biased agonist: AP1189 reduced cytokine release but no melanogenesis was induced.
Related Record Type Details
ACTIVE MOIETY